MX391006B - Sistema de genética inversa del virus pichindé y métodos de uso. - Google Patents
Sistema de genética inversa del virus pichindé y métodos de uso.Info
- Publication number
- MX391006B MX391006B MX2017003694A MX2017003694A MX391006B MX 391006 B MX391006 B MX 391006B MX 2017003694 A MX2017003694 A MX 2017003694A MX 2017003694 A MX2017003694 A MX 2017003694A MX 391006 B MX391006 B MX 391006B
- Authority
- MX
- Mexico
- Prior art keywords
- coding region
- methods
- reverse genetics
- genetics system
- region encoding
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 108091026890 Coding region Proteins 0.000 abstract 5
- 241000712910 Pichinde mammarenavirus Species 0.000 abstract 3
- 102000011931 Nucleoproteins Human genes 0.000 abstract 2
- 108010061100 Nucleoproteins Proteins 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10041—Use of virus, viral particle or viral elements as a vector
- C12N2760/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462053443P | 2014-09-22 | 2014-09-22 | |
| PCT/US2015/051337 WO2016048949A1 (en) | 2014-09-22 | 2015-09-22 | Pichinde virus reverse genetics system and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017003694A MX2017003694A (es) | 2017-10-12 |
| MX391006B true MX391006B (es) | 2025-03-21 |
Family
ID=54238628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003694A MX391006B (es) | 2014-09-22 | 2015-09-22 | Sistema de genética inversa del virus pichindé y métodos de uso. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10533159B2 (https=) |
| EP (1) | EP3198008B1 (https=) |
| JP (1) | JP6875274B6 (https=) |
| KR (1) | KR20170057384A (https=) |
| CN (1) | CN107109371A (https=) |
| AU (1) | AU2015321557B2 (https=) |
| BR (1) | BR112017005744B1 (https=) |
| CA (1) | CA2961913A1 (https=) |
| ES (1) | ES2746150T3 (https=) |
| MX (1) | MX391006B (https=) |
| PL (1) | PL3198008T3 (https=) |
| WO (1) | WO2016048949A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107109371A (zh) | 2014-09-22 | 2017-08-29 | 明尼苏达大学评议会 | 皮钦德病毒反向遗传学系统及其使用方法 |
| SI3218504T1 (sl) * | 2014-11-13 | 2020-11-30 | Universite De Geneve | Tri-segmentirani arenavirusi kot vakcinski vektorji |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| CA3003557A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| DK3373959T3 (da) | 2015-11-12 | 2022-09-19 | Hookipa Biotech Gmbh | Arenaviruspartikler som cancervacciner |
| IL262963B2 (en) * | 2016-05-18 | 2025-01-01 | Hookipa Biotech Gmbh | Trisegmented PICHINDE viruses as vaccine vectors |
| US20230310574A1 (en) * | 2020-08-06 | 2023-10-05 | Regents Of The University Of Minnesota | Multivalent vaccines against turkey arthritis reovirus |
| WO2022269362A2 (en) | 2021-06-21 | 2022-12-29 | Vaxxinova International B.V. | Veterinary viral vector |
| WO2024155646A1 (en) * | 2023-01-17 | 2024-07-25 | Regents Of The University Of Minnesota | Multivalent vaccines against tuberculosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2170622B1 (es) | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
| ES2424214T3 (es) | 2007-08-27 | 2013-09-30 | Siga Technologies, Inc. | Medicamentos antivirales para el tratamiento de una infección por Arenavirus |
| AP3126A (en) | 2007-12-21 | 2015-02-28 | Government Of The Us Secretary | Recombinant rift valley fever (RVF) viruses and methods of use |
| SI2604695T1 (sl) * | 2007-12-27 | 2023-03-31 | Universitaet Zuerich Prorektorat Forschung | Replikacijsko defektni arenavirusni vektorji |
| EP2478103A4 (en) | 2009-09-16 | 2014-02-19 | Univ Tulane | LASSAVIRUS-like PARTICLES AND METHOD FOR THE PRODUCTION THEREOF |
| GB201007790D0 (en) | 2010-05-10 | 2010-06-23 | Isis Innovation | Compositions |
| JP2013531496A (ja) | 2010-06-06 | 2013-08-08 | モウント シナイ スクール オフ メディシネ | 組換えｒｎａウイルス及びその使用 |
| CN107109371A (zh) | 2014-09-22 | 2017-08-29 | 明尼苏达大学评议会 | 皮钦德病毒反向遗传学系统及其使用方法 |
-
2015
- 2015-09-22 CN CN201580063072.3A patent/CN107109371A/zh active Pending
- 2015-09-22 EP EP15772173.9A patent/EP3198008B1/en active Active
- 2015-09-22 BR BR112017005744-1A patent/BR112017005744B1/pt active IP Right Grant
- 2015-09-22 PL PL15772173T patent/PL3198008T3/pl unknown
- 2015-09-22 AU AU2015321557A patent/AU2015321557B2/en active Active
- 2015-09-22 CA CA2961913A patent/CA2961913A1/en active Pending
- 2015-09-22 JP JP2017515764A patent/JP6875274B6/ja active Active
- 2015-09-22 US US15/513,045 patent/US10533159B2/en active Active
- 2015-09-22 MX MX2017003694A patent/MX391006B/es unknown
- 2015-09-22 KR KR1020177010589A patent/KR20170057384A/ko not_active Withdrawn
- 2015-09-22 WO PCT/US2015/051337 patent/WO2016048949A1/en not_active Ceased
- 2015-09-22 ES ES15772173T patent/ES2746150T3/es active Active
-
2019
- 2019-12-10 US US16/708,825 patent/US11993789B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170057384A (ko) | 2017-05-24 |
| PL3198008T3 (pl) | 2020-03-31 |
| EP3198008B1 (en) | 2019-05-29 |
| ES2746150T3 (es) | 2020-03-04 |
| WO2016048949A1 (en) | 2016-03-31 |
| BR112017005744B1 (pt) | 2023-11-28 |
| US11993789B2 (en) | 2024-05-28 |
| BR112017005744A2 (pt) | 2017-12-12 |
| CN107109371A (zh) | 2017-08-29 |
| US20200165578A1 (en) | 2020-05-28 |
| AU2015321557B2 (en) | 2020-05-14 |
| US20170292119A1 (en) | 2017-10-12 |
| AU2015321557A1 (en) | 2017-04-06 |
| JP6875274B2 (ja) | 2021-05-19 |
| EP3198008A1 (en) | 2017-08-02 |
| CA2961913A1 (en) | 2016-03-31 |
| JP2017529084A (ja) | 2017-10-05 |
| US10533159B2 (en) | 2020-01-14 |
| MX2017003694A (es) | 2017-10-12 |
| JP6875274B6 (ja) | 2021-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX391006B (es) | Sistema de genética inversa del virus pichindé y métodos de uso. | |
| CY1124845T1 (el) | Μεθοδοι παροχης μονοκλωνου rna | |
| CY1122705T1 (el) | Αντιγονα, διαβιβαστες, συνθεσεις του ιου της ανθρωπινης ανοσοανεπαρκειας,και μεθοδοι χρησης τους | |
| CY1123642T1 (el) | Αντισωματα enanti-pd-1 | |
| CL2019001480A1 (es) | Receptores inmunes sintéticos y métodos de uso de los mismos. | |
| CO2019006541A2 (es) | Administración viral de neoantígenos | |
| CY1119093T1 (el) | Ανοσο-ρυθμιστικο προγονικο (imp) κυτταρο | |
| CL2018001051A1 (es) | Vacunas de ácido nucleico contra el virus varicela zoster (vzv) | |
| MX2023013729A (es) | Receptores quimericos de flt3 y metodos de uso de los mismos. | |
| DK3400290T3 (da) | Onkolytisk virusstamme | |
| CY1120740T1 (el) | Βελτιωμενα ευλογοϊικα εμβολια | |
| CY1123654T1 (el) | Αποδεσμευση πρωτεϊνης me βαση βακτηρια | |
| MX2016011686A (es) | Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc). | |
| CY1122214T1 (el) | Αντισωματα ειδικα για ton fcrn | |
| CL2017002881A1 (es) | Anticuerpos anti-fcrn | |
| MX383596B (es) | Moleculas biespecificas que son inmunorreactivas con celulas efectoras inmunes que expresan un receptor activador y un antigeno expresado por una celula infectada por un virus y usos de las mismas. | |
| BR112016020287A2 (pt) | células resistentes a vírus e usos das mesmas | |
| MX2018015755A (es) | Proteinas de hemaglutinina de virus de influenza y usos de las mismas. | |
| PL3035245T3 (pl) | Sposób rozpoznawania typu pojazdu i system szybkiej kontroli pojazdu przy użyciu wspomnianego sposobu | |
| EA201790717A1 (ru) | Способы и композиции для индукции защитного иммунитета против инфекции вирусом иммунодефицита человека | |
| TW201613178A (en) | Antenna system | |
| CY1124727T1 (el) | Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων | |
| MX378857B (es) | Celulas huespedes modificadas y usos de las mismas. | |
| MX387400B (es) | Células de mamífero que expresan antígenos de citomegalovirus. | |
| BR112016019837A2 (pt) | plasmídeos imunoestimuladores |